Harvest One (TSXV: HVT) (“Harvest One” or the “Company”) is pleased to announce it is adding four seasoned executives to its Board of Directors, Advisory Board and Senior Leadership Team as it continues to strengthen the H1 team on its mission to become a trusted global leader in developing and providing innovative lifestyle and wellness products to consumers in regulated markets around the world.
Frank Holler, President and CEO of Ponderosa Capital Inc., joins the Harvest One Board of Directors. An expert in biotechnology, investment banking and venture capital, Mr. Holler previously served as CEO and Partner of Lions Capital Corp., fund manager for BC Advantage Funds and the Lions Funds; as President and CEO of Xenon Pharmaceuticals Inc., a private genomics-based drug development company; as President and CEO of ID Biomedical Corporation, a vaccine development company sold to GlaxoSmithKline plc; and as a founding director of Angiotech Pharmaceuticals, a TSX/ NASDAQ listed medical device company. Before working in biotechnology and healthcare, Mr. Holler was an Investment Banker with Merrill Lynch Canada and Wood Gundy Inc. (now CIBC World Markets). Mr. Holler’s experience, particularly in the pharmaceutical industry and capital markets, strengthens the depth of expertise on the Harvest One Board.
David Hyde, Chief Operating Officer at Total Cannabis Security Solutions Inc., joins the newly formed Harvest One Advisory Board. One of the country’s top security and compliance consultants, Mr. Hyde founded David Hyde & Associates Inc. which consulted on 65 Licensed Producer sites and more than 300 Licensed Producer applications to help LPs navigate security and compliance in the highly regulated legal cannabis industry. Mr. Hyde is the only Canadian member of the Security Committee for the Foundation of Cannabis Unified Standards.
Ann Gallery joins Harvest One as Senior Vice President of Corporate Communications. Ms. Gallery is responsible for managing internal and external communications at Harvest One and its wholly-owned subsidiaries United Greeneries (cultivation), Satipharm (medical and nutraceutical), and Dream Water Global (consumer). Before joining Harvest One, Ms. Gallery worked in corporate communications at RBC and Rogers, led national account teams at National Public Relations and Optimum Public Relations, launched a workplace wellness company, and founded a national PR agency in 2001 that serviced global brands including Campbell’s, Heinz, Birks and Revlon.
Gord Davey joins Harvest One as Senior Vice President of Global Sales for Harvest One’s cultivation, medical and nutraceutical, and consumer subsidiaries and is responsible for strategic planning, execution, sales structure and leadership. Mr. Davey comes to Harvest One with more than 20 years in the consumer-packaged goods industry, successfully leading teams and launches at Coca-Cola, Red Bull and Puratos. He will help accelerate the growth and development of Harvest One brands in Canada and throughout the world.
“I’m delighted to have these four exceptional executives join the Harvest One team,” says Grant Froese, CEO, Harvest One. “With the assets we have including our people, businesses, and relationships, Harvest One is well-equipped to become a major player in the global cannabis and wellness markets and bring truly exceptional products to consumers and patients across the globe.”
The Company has granted 1,250,000 stock options under its incentive stock option plan to certain of the Company’s employees, advisors and directors. Each stock option entitles the holder to purchase one common share at an exercise price of $0.91 for a period of five years following the grant date.
Additionally, Andreas Gedeon, formerly CEO and Director, is no longer with the Company.
About Harvest One
Harvest One is a global cannabis company that develops and provides innovative lifestyle and wellness products to consumers and patients in regulated markets around the world. The Company’s range of lifestyle solutions is designed to enhance quality of life. Shareholders have significant exposure to the entire cannabis value chain through three wholly-owned subsidiaries: United Greeneries, a Licensed Producer; Satipharm (medical and nutraceutical); and Dream Water Global (consumer). For more information, please visit www.harvestone.com.
For further information: Colin Clancy, Investor Relations, + 1 (877) 915-7934, email@example.com